NVS
Novartis AG · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -6.5% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 239.53K | $32.26M | n/a | n/a |
| Q2 2026 | 123 | 0 | 102.12M | $16.00B | +8 | −9 |
| Q1 2026 | 126 | +1 | 113.27M | $17.29B | +8 | −7 |
| Q4 2025 | 124 | +1 | 102.45M | $14.13B | +1 | n/a |
| Q3 2025 | 20 | -1 | 49.48M | $6.35B | n/a | −1 |
| Q2 2025 | 18 | 0 | 41.97M | $5.08B | +2 | −2 |
| Q1 2025 | 16 | +1 | 41.02M | $4.58B | +1 | n/a |
| Q4 2024 | 15 | +1 | 35.01M | $3.41B | +1 | n/a |
| Q3 2024 | 13 | 0 | 33.66M | $3.89B | n/a | n/a |
| Q2 2024 | 13 | n/a | 33.92M | $3.61B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 10.65M | -9.9% | $1.29B | 0.7% | ▼ Trim | 5 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 10.40M | +0.2% | $1.26B | 1.0% | ▲ Add | 5 | SEC ↗ |
| 3 | Fisher Asset Management ✦ | 7.12M | +5.3% | $861.76M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.50M | -16.3% | $302.81M | 0.1% | ▼ Trim | 5 | SEC ↗ ×3 |
| 5 | BlackRock ✦ (passief) | 2.32M | n/a | $280.88M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 6 | Renaissance Technologies ✦ | 2.30M | +0.5% | $278.10M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passief) | 1.60M | +0.8% | $195.55M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 1.54M | n/a | $186.47M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 9 | Marshall Wace ✦ | 1.43M | -0.1% | $173.26M | 0.2% | ▼ Trim | 3 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 840.77K | +98.4% | $101.74M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 746.71K | -31.0% | $90.36M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 334.50K | +317.6% | $40.48M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 13 | Tweedy, Browne ✦ | 77.27K | -4.6% | $9.35M | 0.9% | ▼ Trim | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 73.51K | +225.7% | $8.90M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 15 | Adage Capital Partners ✦ | 14.48K | Nieuw | $1.75M | 0.0% | New | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 12.57K | -65.0% | $1.52M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 6.54K | -87.6% | $792,000 | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 18 | Gotham Asset Management ✦ | 1.76K | Nieuw | $213,583 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Adage Capital Partners | $1.75M | 0.0% |
| Gotham Asset Management | $213,583 | 0.0% |
Verlaten
| Citadel Advisors | $119.01M | was 0.1% |
| Arrowstreet Capital | $102.22M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 2 houders, 1.31M aandelen, $431.09M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.